Valuation check: GMVD's profit margin is 157.6%, above the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2021
Trailing 12 months ending Dec 2021
The latest profit margin for GMVD is 157.6% as of December 2021. That compares with -941.84% in the prior-year period — up 116.7% year over year. That is above the Healthcare sector average of 14.34%. Investors often review this figure alongside G Medical Innovations Holdings Limited's historical trend and sector peers before judging valuation or financial health.
Over the past year, GMVD's profit margin moved from -941.84% to 157.6% — a 116.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in G Medical Innovations Holdings Limited's valuation or profitability profile.
Against Healthcare companies, GMVD currently prints 157.6% for profit margin, while the sector average sits near 14.34%. That is roughly 998.6% above the sector mean. Large gaps often invite a closer look at G Medical Innovations Holdings Limited's growth, margins, and balance sheet.
Profit Margin shows how effectively G Medical Innovations Holdings Limited converts resources into returns. At 157.6%, GMVD may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -941.84% in the prior-year period — up 116.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting GMVD's profit margin (157.6%), review year-over-year change from -941.84%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.